Last updated on July 2017

Fosfomycin i.v. for Treatment of Severely Infected Patients


Brief description of study

The purpose of this European, multicentric, prospective, non-interventional study is to document and evaluate the efficacy and safety of the treatment of severely infected patients with intravenously administered fosfomycin, including patients with osteomyelitis, complicated urinary tract infection, nosocomial lower respiratory tract infection, bacterial meningitis/central nervous system infection, bacteraemia/sepsis, skin and soft tissue infection, endocarditis or other infections, each as far as covered by the respective nationally relevant SmPC.

Clinical Study Identifier: NCT02979951

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Claudia Spieß, Prof.

Universit tsmedizin Charit
Berlin, Germany
  Connect »

Thomas Borrmann, Dr.

Vivantes Kliniken Neuk lln
Berlin, Germany
  Connect »

Thomas Borrmann, Dr.

Universit ts D sseldorf; Klinik f r An sthesiologie
Dusseldorf, Germany
  Connect »

Patrick Meybohm, Prof.

Universit tsklinikum Frankfurt
Frankfurt, Germany
  Connect »

Stefan Kluge, Prof.

Universit t Hamburg-Eppendorf
Hamburg, Germany
  Connect »

Mathias Pletz, Prof.

Universit tsklinikum Jena; Zentrum f r Infektionsmedizin
Jena, Germany
  Connect »

Norbert Weiler, Prof.

Universit tsklinikum Schleswig-Holstein
Kiel, Germany
  Connect »

Michael Zoller, Dr.

LMU M nchen
München, Germany
  Connect »

Andreas Weyland, Prof.

Klinikum Oldenburg
Oldenburg in Holstein, Germany
  Connect »

Martin Kieninger, Dr. med.

Universit tsklinik Regensburg; Klinik f r An sthesiologie
Regensburg, Germany
  Connect »